Advertisement
Canada markets closed

  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CAD/USD

    0.7322
    +0.0001 (+0.02%)
     

  • CRUDE OIL

    83.34
    -0.02 (-0.02%)
     

  • Bitcoin CAD

    90,951.30
    -87.43 (-0.10%)
     

  • CMC Crypto 200

    1,433.51
    +18.75 (+1.33%)
     

  • GOLD FUTURES

    2,334.10
    -8.00 (-0.34%)
     

  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     

  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     

  • NASDAQ futures

    17,733.25
    +126.50 (+0.72%)
     

  • VOLATILITY

    15.69
    -1.25 (-7.38%)
     

  • FTSE

    8,044.81
    +20.94 (+0.26%)
     

  • NIKKEI 225

    38,329.39
    +777.23 (+2.07%)
     

  • CAD/EUR

    0.6833
    -0.0003 (-0.04%)
     

Morgan Stanley Sticks to Their Hold Rating for Envista Holdings Corp

Investing.com
·2 min read


Morgan Stanley (NYSE:MS) analyst David Lewis maintained a Hold rating on Envista Holdings (NYSE:NVST) Corp on Thursday, setting a price target of $18, which is approximately 12.71% above the present share price of $15.97.

Lewis expects Envista Holdings Corp to post earnings per share (EPS) of $0.35 for the second quarter of 2020.

The current consensus among 5 TipRanks analysts is for a Moderate Buy rating of shares in Envista Holdings, with an average price target of $21.4.
The analysts price targets range from a high of $27 to a low of $18.

In its latest earnings report, released on 12/31/2019, the company reported a quarterly revenue of $720.5 million and a net profit of $78 million. The company's market cap is $2.51 billion.

ADVERTISEMENT

According to TipRanks.com, Morgan Stanley analyst David Lewis is a 5-star analyst with an average return of 8.0% and a 60.4% success rate.

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The firm operates through the following segments; Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded on August 29, 2018 and is headquartered in Brea, CA.